ALL-Contributions for the Information Letter

About us

The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.

Lastest Posts

---

---

---

Links

• CML-Collaboration
• Cytogenetics
• SCT
• Supportive Care

Kontakt-Info

ELN-Foundation
Im Langgewann 45
69469 Weinheim, Germany

Hehlmann.ELN@gmail.com

www.elnfoundation.org